ADLUMA

Welcome to the Brand page for “ADLUMA”, which is offered here for Pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of viral diseases; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the prevention and treatment of central nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neurodegenerative diseases and disorders; and pharmaceutical preparations for the prevention and treatment of very mild dementia of the alzheimer's type, also known as mild cognitive impairment, mci, or prodromal alzheimer's disease, and mild, moderate, and severe dementia of the alzheimer's type;.

Its status is currently believed to be active. Its class is unavailable. “ADLUMA” is believed to be currently owned by “Myriad Pharmaceuticals, Inc.”